Your browser doesn't support javascript.
loading
CD33-targeting extracellular vesicles deliver antisense oligonucleotides against FLT3-ITD and miR-125b for specific treatment of acute myeloid leukaemia.
Chen, Huan; Jayasinghe, Migara Kavishka; Yeo, Eric Yew Meng; Wu, Zhiyuan; Pirisinu, Marco; Usman, Waqas Muhammad; Pham, Thach Tuan; Lim, Kah Wai; Tran, Nhan Van; Leung, Anskar Y H; Du, Xin; Zhang, Qiaoxia; Phan, Anh Tuân; Le, Minh T N.
Afiliación
  • Chen H; Department of Pharmacology, Institute for Digital Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Jayasinghe MK; Department of Surgery, Immunology Program, Cancer Program and Nanomedicine Translational Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Yeo EYM; Department of Biomedical Sciences, Jockey Club College of Veterinary Medicine and Life Sciences, City University of Hong Kong, Kowloon, Hong Kong SAR.
  • Wu Z; Department of Pharmacology, Institute for Digital Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Pirisinu M; Department of Surgery, Immunology Program, Cancer Program and Nanomedicine Translational Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Usman WM; Department of Pharmacology, Institute for Digital Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Pham TT; Department of Surgery, Immunology Program, Cancer Program and Nanomedicine Translational Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Lim KW; Department of Pharmacology, Institute for Digital Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Tran NV; Department of Surgery, Immunology Program, Cancer Program and Nanomedicine Translational Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Leung AYH; Department of Biomedical Sciences, Jockey Club College of Veterinary Medicine and Life Sciences, City University of Hong Kong, Kowloon, Hong Kong SAR.
  • Du X; Department of Biomedical Sciences, Jockey Club College of Veterinary Medicine and Life Sciences, City University of Hong Kong, Kowloon, Hong Kong SAR.
  • Zhang Q; Department of Pharmacology, Institute for Digital Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Phan AT; Department of Surgery, Immunology Program, Cancer Program and Nanomedicine Translational Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Le MTN; Division of Physics & Applied Physics, School of Physical & Mathematical Sciences, Nanyang Technological University, Singapore, Singapore.
Cell Prolif ; 55(9): e13255, 2022 Sep.
Article en En | MEDLINE | ID: mdl-35851970
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / MicroARNs / Vesículas Extracelulares Límite: Adult / Humans Idioma: En Revista: Cell Prolif Año: 2022 Tipo del documento: Article País de afiliación: Singapur
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / MicroARNs / Vesículas Extracelulares Límite: Adult / Humans Idioma: En Revista: Cell Prolif Año: 2022 Tipo del documento: Article País de afiliación: Singapur